Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meningococcal ABCWY Vaccine in Healthy Volunteers
NCT04886154Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2021
- Primary completion
- Feb 2024
- Countries
- 8
01
Overview
A Phase 2 trial of MENABCWY-1GEN in invasive meningococcal disease (IMD), sponsored by GSK. Started Jun 2021; status: completed.
02
Drugs
MENABCWY-1GEN
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT04886154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886154.